This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Strategies to enhance CAR-T persistence
Biomarker Research Open Access 23 November 2022
-
A digital platform for the design of patient-centric supply chains
Scientific Reports Open Access 17 October 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
First CAR-T therapy to target BCMA gets FDA nod. Nat Biotechnol 39, 531 (2021). https://doi.org/10.1038/s41587-021-00929-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-021-00929-0
This article is cited by
-
Strategies to enhance CAR-T persistence
Biomarker Research (2022)
-
A digital platform for the design of patient-centric supply chains
Scientific Reports (2022)